skip to Main Content

Aditi Hazra, PhD, MPH

Assistant Professor of Medicine, Harvard Medical School
Associate Epidemiologist, Brigham and Women’s Hospital

Dr. Hazra received her PhD in cancer biology from The University of Texas M.D. Anderson Cancer Center and was a post-doctoral fellow in the Program in Molecular and Genetic Epidemiology at the Harvard T.H. Chan School of Public Health. To identify clinically actionable biomarkers, she has led translational and collaborative research on gene regulation in cancer, including studies on germline genetic risk, nutritional genomics, cancer genomics and epigenomics. Her current research is on breast cancer genomics and her future goals are to design a strength training survivorship trial in partnership with the community. Dr. Hazra’s American Cancer Society funded research aims to evaluate the transcriptome and improve stratification of subsequent breast cancer risk among racially diverse DCIS (ductal carcinoma in situ) patients. The completion of the “precision health equity” aims may lead to personalized treatment for all DCIS patients and may prevent DCIS progression to invasive breast cancer. As a Fulbright Specialist candidate in global health, Dr. Hazra aims to improve awareness, early detection of breast cancer, and survivorship for all women.

MPH: University of Texas, Houston
PhD: UT M.D. Anderson Cancer and UT Graduate School of Biomedical Sciences

  1. Hazra A, Kraft P, Selhub J, Giovannucci EL, Thomas G, Hoover RN, Chanock SJ, Hunter DJ. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet. 2008 Oct;40(10):1160-2. PMCID: PMC2673801.
  2. Hazra A, Chanock S, Giovannucci EL, Cox DG, Niu T, Fuchs CS, Willett WC, Hunter DJ. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses’ Health Study and the Health Professionals Follow-up Study. CEBP 2008; 311-319.
  3. Healey MA, Hu R, Beck AH, Collins L, Schnitt SJ, Tamimi RM, Hazra A. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study. Breast Cancer Research & Treatment. 2014 Oct;147(3):639-51. PMID: 25224916
  4. Quiroz-Zarate A, Harshfield B, Knoblauch N, Hu R, Beck AH, Hankinson SE, Carey V, Tamimi RM, Hunter, DJ, Quackenbush J, Hazra A. Expression Quantitative Trait loci (QTL) in Normal Adjacent Breast Tissue and Breast Tumor Tissue. 2017. PLoS ONE 12(2): e0170181. PMCID: PMC5289428
  5. Vyas CM, Hazra A, Chang SC, Qiu W, Reynolds CF, 3rd, Mischoulon D, et al. Pilot study of DNA methylation, molecular aging markers and measures of health and well-being in aging. Transl Psychiatry. 2019;9(1):118. PMCID: PMC6423054

Full Listing of Publications

Back To Top